United States Thyroid Eye Disease Market Size & Outlook, 2026-2034


United States Thyroid Eye Disease Market Insights

  • According to Reed Intelligence analysis, the United States Thyroid Eye Disease Market size was USD 312.35 Million in 2025 and is projected to reach USD 566.38 Million by 2034.
  • The United States market is projected to grow at a CAGR of 6.88% between 2026 and 2034.
  • By segment, Biologics emerged as the largest Therapy Type in terms of market size in 2025.
  • Corticosteroids is anticipated to remain the most attractive Therapy Type segment, recording the fastest growth during the forecast period.

Other Key Findings


  • In 2025, United States accounted for 26.47% of the global Thyroid Eye Disease Market size.
  • By 2034, United States is expected to lead the global Thyroid Eye Disease Market in terms of market size.
  • Within North America, United States is projected to dominate the regional Thyroid Eye Disease Market size by 2034.
  • Canada is identified as the fastest-growing market in North America, anticipated to reach USD 180.03 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 312.35 Million
Market Size In 2034 USD 566.38 Million
Largest segment Biologics
Units Revenue in USD Million
CAGR 6.88% (2026-2034)
Segmnetation Covered
Therapy Type
  1. Biologics
  2. Small Molecule Drugs
  3. Corticosteroids
Treatment Approach
  1. Pharmacological Therapy
  2. Combination Therapy
  3. Surgical Intervention
Distribution Channel
  1. Hospital Pharmacies
  2. Retail Pharmacies
  3. Online Pharmacies
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports